8-K
Current Report
Oruka Therapeutics, Inc. Filed Acc 0001564590-22-023734
Material agreement · Executive or director change
- Item 1.01 Entry into a material definitive agreement
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading abio-8k_20220615.htm…